Elisabeth Gröne

3.3k total citations
54 papers, 2.7k citations indexed

About

Elisabeth Gröne is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Elisabeth Gröne has authored 54 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Nephrology and 13 papers in Surgery. Recurrent topics in Elisabeth Gröne's work include Renal Diseases and Glomerulopathies (13 papers), Cholesterol and Lipid Metabolism (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Elisabeth Gröne is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Cholesterol and Lipid Metabolism (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Elisabeth Gröne collaborates with scholars based in Germany, United States and France. Elisabeth Gröne's co-authors include Hermann-Josef Gröne, Hermann‐Josef Gröne, Detlef Schlöndorff, Autar K. Walli, H.-J. Gröne, Peter J. Nelson, Matthias Kretzler, Clemens D. Cohen, Udo Helmchen and Mathias Simon and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Elisabeth Gröne

53 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Gröne Germany 30 1.1k 679 620 446 394 54 2.7k
Yoshihiko Ueda Japan 28 912 0.8× 659 1.0× 288 0.5× 378 0.8× 521 1.3× 150 2.9k
Giacomo DellʼAntonio Italy 21 1.3k 1.2× 320 0.5× 777 1.3× 310 0.7× 346 0.9× 60 3.1k
Alistair J. Ingram Canada 38 2.1k 1.9× 677 1.0× 362 0.6× 350 0.8× 427 1.1× 73 3.8k
Keiju Hiromura Japan 29 1.1k 1.0× 1.2k 1.8× 866 1.4× 246 0.6× 441 1.1× 123 3.4k
Jun Peng China 38 962 0.9× 320 0.5× 1.1k 1.7× 284 0.6× 380 1.0× 158 4.5k
Jan Menne Germany 25 1.2k 1.1× 878 1.3× 664 1.1× 378 0.8× 305 0.8× 68 3.2k
Ryuji Ohashi Japan 21 684 0.6× 423 0.6× 249 0.4× 427 1.0× 323 0.8× 119 1.8k
Junichi Hirahashi Japan 24 882 0.8× 277 0.4× 719 1.2× 275 0.6× 378 1.0× 49 2.3k
Ana Tobar Israel 22 645 0.6× 399 0.6× 274 0.4× 293 0.7× 192 0.5× 51 2.1k
Minoru Sakatsume Japan 23 620 0.6× 613 0.9× 621 1.0× 196 0.4× 177 0.4× 70 2.0k

Countries citing papers authored by Elisabeth Gröne

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Gröne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Gröne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Gröne more than expected).

Fields of papers citing papers by Elisabeth Gröne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Gröne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Gröne. The network helps show where Elisabeth Gröne may publish in the future.

Co-authorship network of co-authors of Elisabeth Gröne

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Gröne. A scholar is included among the top collaborators of Elisabeth Gröne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Gröne. Elisabeth Gröne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jankowski, Vera, Kim Ohl, Juliane Hermann, et al.. (2019). The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus. Kidney International. 97(2). 289–303. 20 indexed citations
2.
Olaru, Florina, Anke S. Lonsdorf, Alexander Enk, et al.. (2018). Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis. JCI Insight. 3(11). 32 indexed citations
3.
Kriz, Wilhelm, et al.. (2017). Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 312(6). F1101–F1111. 31 indexed citations
4.
Sulaj, Alba, Stefan Kopf, Elisabeth Gröne, et al.. (2017). ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy. Journal of Diabetes and its Complications. 31(6). 1058–1065. 14 indexed citations
5.
Dong, Wei, Khurrum Shahzad, Fabian Bock, et al.. (2015). Activated Protein C Ameliorates Renal Ischemia-Reperfusion Injury by Restricting Y-Box Binding Protein-1 Ubiquitination. Journal of the American Society of Nephrology. 26(11). 2789–2799. 62 indexed citations
7.
Ott, U., Martin Busch, T. Steiner, et al.. (2008). The Case ∣ Renal failure, sepsis, and bilateral kidney tumors. Kidney International. 73(6). 787–788. 3 indexed citations
8.
Segerer, Stephan, Maja T. Lindenmeyer, Holger Schmid, et al.. (2008). Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney International. 74(1). 37–46. 104 indexed citations
9.
Koziolek, Michael, Peter F. Zipfel, Christine Skerka, et al.. (2008). Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3). Kidney International. 74(3). 384–388. 8 indexed citations
10.
Ott, U., et al.. (2008). Cholesterol embolization in a renal graft. Clinical Transplantation. 22(5). 677–680. 3 indexed citations
11.
Guthoff, Martina, R. Teichmann, Elisabeth Gröne, et al.. (2008). Hyperkalzämische Krise infolge eines primären Hyperparathyreoidismus. DMW - Deutsche Medizinische Wochenschrift. 133(50). 2639–2643. 3 indexed citations
12.
Gröne, Elisabeth & Hermann-Josef Gröne. (2008). Does hyperlipidemia injure the kidney?. Nature Clinical Practice Nephrology. 4(8). 424–425. 15 indexed citations
13.
Wagener, Nina, Irena Crnković‐Mertens, Stephan Macher-Göppinger, et al.. (2007). Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney. British Journal of Cancer. 97(9). 1271–1276. 29 indexed citations
14.
Devens, Frauke, Axel Benner, Elisabeth Gröne, et al.. (2006). Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. British Journal of Cancer. 96(1). 82–88. 64 indexed citations
15.
Ernst, Thomas, et al.. (2003). Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. British Journal of Cancer. 89(4). 687–690. 30 indexed citations
16.
Gröne, Hermann-Josef, Elisabeth Gröne, & Ernst Malle. (2002). Immunohistochemical Detection of Hypochlorite-Modified Proteins in Glomeruli of Human Membranous Glomerulonephritis. Laboratory Investigation. 82(1). 5–14. 66 indexed citations
17.
Gröne, Elisabeth, H.-J. Gröne, Matthias Kretzler, et al.. (1999). Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice1. Kidney International. 56(4). 1423–1431. 159 indexed citations
18.
Gröne, H.-J., Autar K. Walli, & Elisabeth Gröne. (1997). The Role of Oxidatively Modified Lipoproteins in Lipid Nephropathy. Contributions to nephrology. 120. 160–175. 11 indexed citations
19.
Gröne, H.-J., et al.. (1996). Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins.. PubMed. 54. S18–22. 33 indexed citations
20.
Gröne, Hermann‐Josef, Mathias Simon, & Elisabeth Gröne. (1995). Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. The Journal of Pathology. 177(3). 259–267. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026